Elan announces shareholder approval of its acquisition by Perrigo company
MLex Summary: Shareholders of NYSE-listed Irish drugmaker Elan have approved the acquisition of Elan by NYSE-listed pharmaceutical company Perrigo for $8.6 billion on Monday.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article